Get started
Author

Yvette Ellis

COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study
2021 · Victoria Jane Hall, Sarah Foulkes, et al. · The Lancet · 766
PDF
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
2021 · Rachael A Evans, Hamish J C McAuley, et al. · The Lancet Respiratory Medicine · 672
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
2021 · Victoria Jane Hall, Sarah Foulkes, et al. · The Lancet · 639
PDF
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 533
PDF
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 493
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
2022 · R A Evans, O C Leavy, et al. · The Lancet Respiratory Medicine · 413
PDF
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 369
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 324
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 290
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19
2021 · Hesham Abdelhady, Marwa Abdelrazik, et al. · JAMA · 210
PDF
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
2022 · Simin  Florescu, Delia Stanciu, et al. · JAMA · 136
PDF
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 129
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
2022 · Felicity Liew, Shubha Talwar, et al. · EBioMedicine · 121
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease
2024 · Felicity Liew, Claudia Efstathiou, et al. · Nature Immunology · 107
PDF
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
2021 · Yaseen M. Arabi, Anthony C. Gordon, et al. · Intensive Care Medicine · 99
PDF
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19
2023 · Simin  Florescu, Delia Stanciu, et al. · JAMA · 63
PDF
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study
2023 · Betty Raman, Celeste McCracken, et al. · The Lancet Respiratory Medicine · 57
PDF
Intravenous Vitamin C for Patients Hospitalized With COVID-19
2023 · The LOVIT-COVID Investigators, on behalf of the Canadian Critical Care Trials Group, and the REMAP-CAP Investigators, Simin  Florescu, et al. · JAMA · 53
PDF
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39
PDF
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study
2023 · Callum Jackson, Iain D Stewart, et al. · The Lancet Respiratory Medicine · 35
Accelerated immune ageing is associated with COVID-19 disease severity
2024 · Janet M. Lord, Tonny Veenith, et al. · Immunity & Ageing · 34
PDF
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls
2023 · Bang Zheng, Giulia Vivaldi, et al. · The Lancet Regional Health - Europe · 29
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study
2023 · Hamish J.C. McAuley, Rachael A. Evans, et al. · EClinicalMedicine · 24
PDF
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study
2023 · Omer Elneima, Hamish J C McAuley, et al. · International Journal of Epidemiology · 23
PDF
Works count: 35
Citation count: 5,793
H-index: 24
I10-index: 31
Year
Topic
Type